Baby KJ's doctors plan to request FDA approval for a clinical trial of a pioneering gene editing approach this winter.
The proposed trial would be open to patients with seven different urea cycle disorders.
"This is what we thought we would never get,"
Kyle Muldoon, Baby KJ's father, expressed his emotions after a meaningful moment with his son.
Autor's resume: Baby KJ's gene editing trial.